Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02925026
Other study ID # Lactoferrin-Lysozyme
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date October 2016
Est. completion date December 2017

Study information

Verified date May 2018
Source Washington University School of Medicine
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Randomized, double-blind, placebo controlled trial of daily lactoferrin and lysozyme supplementation in improving environmental enteric dysfunction in Malawian children


Recruitment information / eligibility

Status Completed
Enrollment 235
Est. completion date December 2017
Est. primary completion date December 2017
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 12 Months to 35 Months
Eligibility Inclusion Criteria:

- children aged 12-35 months

- youngest eligible child in each household

Exclusion Criteria:

- severe or moderate acute malnutrition

- severe chronic illness

- children unable to drink 20 mL of dual sugar solution

- children in need of acute medical treatment for illness or injury at time of enrollment

Study Design


Related Conditions & MeSH terms

  • Environmental Enteric Dysfunction

Intervention

Dietary Supplement:
Lactoferrin

Lysozyme

Placebo


Locations

Country Name City State
Malawi Malawi Blantyre

Sponsors (2)

Lead Sponsor Collaborator
Washington University School of Medicine University of Malawi

Country where clinical trial is conducted

Malawi, 

Outcome

Type Measure Description Time frame Safety issue
Other Linear Growth changes in linear growth 16 weeks
Primary Dual Sugar Absorption Test lactulose-mannitol ratio in urine 8 weeks
Primary Dual Sugar Absorption Test lactulose-mannitol ratio in urine 16 weeks
Secondary Lactulose Excretion percentage of ingested lactulose excreted in urine 8 weeks
Secondary Lactulose Excretion percentage of ingested lactulose excreted in urine 16 weeks
Secondary Mannitol Excretion percentage of ingested mannitol excreted in urine 8 weeks
Secondary Mannitol Excretion percentage of ingested mannitol excreted in urine 16 weeks
See also
  Status Clinical Trial Phase
Enrolling by invitation NCT04984447 - OCT Guided Trans Nasal Imaging of the Small Intestine in Adults N/A
Recruiting NCT06002438 - Eggs for Gut Health N/A
Completed NCT03263871 - PTM202 for the Treatment of Environmental Enteric Dysfunction (EED) N/A
Enrolling by invitation NCT04275167 - Capsule Endomicroscopy for Visualization of the Small Intestine in EED Population in Pakistan N/A
Recruiting NCT03313128 - SaniVac Trial - Sanitation and Oral Rotavirus Vaccine Performance
Completed NCT02760095 - Effects of EED on Zn Absorption and Retention in Children From a Standard Dose
Completed NCT02758444 - Effects of EED on Zn Absorption and Retention in Children From a MNP N/A
Recruiting NCT05501470 - Probiotic For the Improvement of Environmental Enteropathy in Pregnant Women in Senegal Phase 2
Recruiting NCT06196450 - Maternal Probiotic Intervention to Improve Gut Health Phase 2
Completed NCT05291559 - Acceptability and Efficacy of Enterade (VS001) in Children at Risk for Environmental Enteric Dysfunction in Bangladesh N/A
Terminated NCT03782272 - Safety, Acceptability, and Feasibility of Enterade® N/A
Completed NCT03801317 - The Effect of Bovine Colostrum/ Egg Supplementation in Young Malawian Children N/A
Recruiting NCT05922683 - Maternal Probiotic Intervention to Improve Gut Health Phase 2